Login / Signup

Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results from a large multicentre observational prospective cohort (SCOLTA).

Lucia TaramassoElena RicciAntonio CascioLaura ValsecchiBarbara MenzaghiNicola SquillacePaolo MaggiGiuseppe Vittorio De SocioChiara DentoneGiordano MadedduGiovanni F PellicanòLeonardo CalzaGoffredo AngioniPaolo BonfantiAntonio Di Biagionull null
Published in: AIDS research and therapy (2019)
DRV/c was safe and well tolerated. Dual therapies showed a better profile of tolerability and a longer durability compared to triple therapies.
Keyphrases
  • hiv infected patients
  • hiv infected
  • human immunodeficiency virus
  • double blind
  • cross sectional
  • clinical trial
  • hiv aids
  • open label
  • study protocol
  • hiv positive
  • antiretroviral therapy
  • randomized controlled trial